Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014

Vaccine

Volumn 34, Issue 4, 2016, Pages 503-509

  Pierse, Nevil ^a   Kelly, Heath ^b,c   Thompson, Mark G ^f   Bissielo, Ange ^d   Radke, Sarah ^e   Huang, Q Sue ^d   Baker, Michael G ^a   Turner, Nikki ^e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Immunisation; Influenza vaccine; Test case negative design; Vaccination; Vaccine effectiveness

Indexed keywords

INFLUENZA VACCINE; INACTIVATED VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HOSPITAL PATIENT; HUMAN; INFANT; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; NONHUMAN; PACIFIC ISLANDER; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY VIRUS; URBAN AREA; VIRUS DETECTION; VIRUS STRAIN; COMPARATIVE STUDY; CONTROL GROUP; GENERAL PRACTICE; HOSPITALIZATION; IMMUNOLOGY; INFLUENZA, HUMAN; MIDDLE AGED; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASES; SENTINEL SURVEILLANCE; STATISTICS AND NUMERICAL DATA; VACCINATION; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CONTROL GROUPS; FEMALE; GENERAL PRACTICE; HOSPITALIZATION; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEW ZEALAND; RESPIRATORY TRACT DISEASES; SENTINEL SURVEILLANCE; VACCINATION; VACCINES, INACTIVATED; YOUNG ADULT;

EID: 84952990772     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.11.073     Document Type: Article

References (33)

1. Nair H., et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011, 378(9807):1917-1930.
2. Matias G., et al. Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype: age, cause of death, and risk status. Influenza Respir Viruses 2014, 8(5):507-515.
3. Hoberman A., et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 2003, 290(12):1608-1616.
4. Shuler C.M., et al. Vaccine effectiveness against medically attended: laboratory-confirmed influenza among children aged 6 to 59 months, 2003-2004. Pediatrics 2007, 119(3):e587-e595.
5. Osterholm M.T., et al. Efficacy and effectiveness of influenza vaccines: a systematic review and metaanalysis. Lancet Infect Dis 2011, 12(1):36-44.
6. Jefferson T., et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010, 7(7):2-3.
7. Jefferson T., et al. Vaccines for preventing influenza in the elderly (Review) 2010, Cochrane Database Syst Rev 7.
8. Skowronski D.M., et al. Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada. Autumn 2009, 342:2011.
9. Jackson M.L., Nelson J.C. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013, 31(17):2165-2168.
10. Foppa I.M., et al. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine 2013, 31(30):3104-3109.
11. Turner N., et al. Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014. Euro Surveill 2014, 19(42):19-24.
12. Cowling B.J., Nishiura H. Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. Epidemiology 2012, 23(6):930-931.
13. Cowling B.J., et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis 2012, 54(12):1778-1783.
14. Kelly H., et al. Vaccine effectiveness against laboratory-confirmed influenza in healthy young children: a case-control study. Pediatr Infect Dis J 2011, 30(2):107-111.
15. Sundaram M.E., et al. Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clin Infect Dis 2013, 57(6):789-793.
16. Blyth C.C., et al. Effectiveness of trivalent flu vaccine in healthy young children. Pediatrics 2014, 133(5):e1218-e1225.
17. Huang Q.S., et al. Implementing hospital-based surveillance for severe acute respiratory infections (SARI) caused by influenza and other respiratory pathogens in New Zealand. West Pacific Surveill Response J 2014, 5(2):12-20.
18. Turner N., et al. Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013. Euro Surveill 2014, 19:29-38.
19. Turner N., et al. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland: New Zealand in 2012. Vaccine 2014, 32(29):3687-3693.
20. WHO WHO global epidemiological surveillance standards for influenza February 2014, Available from: 〈http://www.who.int/influenza/resources/documents/influenza_surveillance:manual/en/index.html〉.
21. Jenkinson C., Coulter A., Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ: Br Med J 1993, 306(6890):1437.
22. Crampton P., Salmon C., Kirkpatrick R. Degrees of deprivation in New Zealand: an atlas of socioeconomic difference 2004, D.B. Limited, Auckland, New Zealand. 2nd ed.
23. Shu B., et al. Design and performance of the CDC real-time reverse transcriptase PCR swine flu panel for detection of 2009 A (H1N1) pandemic influenza virus. J Clin Microbiol Infect 2011, 49(7):2614-2619.
24. WHO Global influenza surveillance network, manual for the laboratory diagnosis and virological surveillance of influenza 2011, 153. WHO.
25. Szewczuk E. et al. Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness. BMC Infect Dis 2010, 10(1):113.
26. Lu X., et al. Real-time reverse transcription-PCR assay for comprehensive detection of human rhinoviruses. J Clin Microbiol Infect 2008, 46(2):533-539.
27. Osterholm M.T., et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12(1):36-44.
28. Flannery B., et al. Interim estimates of 2013-14 seasonal influenza vaccine effectiveness-United States: February 2014. MMWR Morb Mortal Wkly Rep 2014, 63(7):137-142.
29. Skowronski D., et al. Interim estimates of 2013/14 vaccine effectiveness against influenza A (H1N1) pdm09 from Canada's sentinel surveillance network, January 2014. Euro Surveill 2014, 19(5):4-18.
30. Pebody R., et al. Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill 2015, 20(5):5.
31. WHO Recommended composition of influenza virus vaccines for use in the 2014-2015 northern hemisphere influenza season 2015, Available from: 〈http://www.who.int/influenza/vaccines/virus/recommendations/2014_15_north/en/〉 [cited 2015 16/02].
32. Skull S.A., et al. Validity of self-reported influenza and pneumococcal vaccination status among a cohort of hospitalized elderly inpatients. Vaccine 2007, 25(25):4775-4783.
33. Ohmit S.E., et al. Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 2014, 58(3):319-327.